Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 1987 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista do Instituto de Medicina Tropical de São Paulo |
Texto Completo: | https://www.revistas.usp.br/rimtsp/article/view/28522 |
Resumo: | Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory. |
id |
IMT-1_60c1c20efe4a7a0adcf1d72770640ddf |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/28522 |
network_acronym_str |
IMT-1 |
network_name_str |
Revista do Instituto de Medicina Tropical de São Paulo |
repository_id_str |
|
spelling |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil Soroepidemiologia de Hepatite A e B em duas comunidades urbanas do Rio de Janeiro, Brasil SoroepidemiologyHBsAg anti-HBs anti-HAV Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory. Foi determinada a prevalência de marcadores de hepatite B em amostras representativas de duas comunidades, Niterói (397) e Nova Iguaçu (680), encontrando-se 9,1% (1,0% de HBsAg e 8,1% de anti-HBs) em Niterójl e 11% (1,7% de HBsAg e 9,3% de anti-HBs) em Nova Iguaçú. Por estudo comparativo em relação à idade, foi verificada maior prevalência de HBsAg no grupo etário de 21 a 50 anos. Em relação a anti-HBs, foi demonstrado um aumento gradual com a idade, alcançando 14,9% em Niterói e 29,1% em Nova Iguaçú nos grupos de indivíduos acima de 51 anos de idade. Em relação a Hepatite A, em 259 amostras de Niterói, foi encontrada a prevalência de 74,5% de anticorpos anti-HAV. Esta prevalência aumentou gradualmente, alcançando 90% a partir de 30 anos. Em 254 amostras de Nova Iguaçu, a prevalência foi de 90,5%. Estes valores já são alcançados em crianças a partir de 10 anos. Todos os testes foram feitos em sistema imunoenzimático padronizado em nosso laboratório. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo1987-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/28522Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 4 (1987); 219-223 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/28522/30375Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessAbuzwaida, Abdulbasit R. N.Sidoni, MarliYoshida, Clara F. T.Schatzmayr, Hermann G.2012-07-02T00:57:39Zoai:revistas.usp.br:article/28522Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:50:15.169816Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true |
dc.title.none.fl_str_mv |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil Soroepidemiologia de Hepatite A e B em duas comunidades urbanas do Rio de Janeiro, Brasil |
title |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
spellingShingle |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil Abuzwaida, Abdulbasit R. N. Soroepidemiology HBsAg anti-HBs anti-HAV |
title_short |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
title_full |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
title_fullStr |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
title_full_unstemmed |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
title_sort |
Seroepidemiology of hepatitis a and b in two urban communities of Rio de Janeiro, Brazil |
author |
Abuzwaida, Abdulbasit R. N. |
author_facet |
Abuzwaida, Abdulbasit R. N. Sidoni, Marli Yoshida, Clara F. T. Schatzmayr, Hermann G. |
author_role |
author |
author2 |
Sidoni, Marli Yoshida, Clara F. T. Schatzmayr, Hermann G. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Abuzwaida, Abdulbasit R. N. Sidoni, Marli Yoshida, Clara F. T. Schatzmayr, Hermann G. |
dc.subject.por.fl_str_mv |
Soroepidemiology HBsAg anti-HBs anti-HAV |
topic |
Soroepidemiology HBsAg anti-HBs anti-HAV |
description |
Hepatitis B markers were determined in 397 individuals from Niterói and 680 from Nova Iguaçu and prevalences of 9.1% (1.0% of HBsAg and 8.1% of anti HBs) and 11.1% (1.8% of HBsAg and 9.3% of antiHBs) were found, respectively. The comparative prevalence of both markers in relation to age showed a higher prevalence of HBsAg in the group 21-50 years old. Considering the antiHBs antibody, it was demostrated a gradual increase with age, reaching 14.9% in Niterói and 29.1% in Nova Iguaçu in individuals over 51 years old. For hepatitis A, in 259 samples from Niterói, equally distributed by age groups, an overall prevalence of 74.5% of anti-HAV antibodies was found. This prevalence increases gradually reaching 90.0% at age over thirty. In 254 samples from Nova Iguaçu analysed, a prevalence of 90.5% of antibodies was encountered when the same criteria of distribution of samples were used. This level of prevalence reached 90.0% already in the age over ten years old. The tests were performed by enzyme immunoassay with reagents prepared in our laboratory. |
publishDate |
1987 |
dc.date.none.fl_str_mv |
1987-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/28522 |
url |
https://www.revistas.usp.br/rimtsp/article/view/28522 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/28522/30375 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
dc.source.none.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 4 (1987); 219-223 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 4 (1987); 219-223 1678-9946 0036-4665 reponame:Revista do Instituto de Medicina Tropical de São Paulo instname:Instituto de Medicina Tropical (IMT) instacron:IMT |
instname_str |
Instituto de Medicina Tropical (IMT) |
instacron_str |
IMT |
institution |
IMT |
reponame_str |
Revista do Instituto de Medicina Tropical de São Paulo |
collection |
Revista do Instituto de Medicina Tropical de São Paulo |
repository.name.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT) |
repository.mail.fl_str_mv |
||revimtsp@usp.br |
_version_ |
1798951637204598784 |